Dr. Prasad received his undergraduate degree with highest honors from Harvard University, a Master’s degree in Epidemiology with Distinction from the University of Cambridge (England), and his medical degree from the Duke University School of Medicine (where he graduated Alpha Omega Alpha). He completed his urology training at the Harvard Program in Urology and a 2-year Society of Urologic Oncology minimally-invasive urologic oncology fellowship at the University of Chicago prior to coming to MUSC. He serves as the Program Director of the MUSC Urology Residency Program.
Dr. Prasad's clinical and research interests are focused in prostate, urothelial (bladder and upper urinary tract), renal, and testicular cancers. He performs open and minimally-invasive (endoscopic, laparoscopic, and robotic) surgical procedures. He has served as the principal investigator or coinvestigator on multiple clinical trials funded by the National Institutes of Health as well as industry. He is primarily interested in optimizing health outcomes for patients with urologic disease through judicious use of screening and treatment. His research has been published in over 50 journal articles in the Journal of the American Medical Association, the Journal of Clinical Oncology, Cancer, the Journal of Urology, Urology, and Urologic Oncology, among others. His teaching and clinical interests have been recognized with several awards, including the Travelling Fellowship Award from the North Central Section of the AUA, the John Quale Travel Fellowship Award for Young Investigators from the Bladder Cancer Advocacy Network, the ASCO Cancer Foundation Merit Award, the Gerald P. Murphy Scholar Award from the AUA as well as the Medical Student Teaching Award from Harvard Medical School.